Abstract
Background and aims
Acute-on-chronic liver failure (ACLF) is a distinct clinical entity with high probability of organ failure and mortality. Since patients generally present late, experimental models are needed to understand the pathophysiology and natural course of the disease.
Methodology
To reproduce the syndrome of ACLF, chronic liver disease was induced in C57BL6 mice (6–8 weeks; approximately 20–24 g weight) by intraperitoneal administration of carbon tetrachloride (CCl4) for 10 weeks followed by an acute injury with acetaminophen (APAP) and lipopolysaccharide (LPS). Blood, ascitic fluid, and organs were collected to study cell death, regeneration, and fibrosis.
Results
At 24 h post-APAP/LPS infusion, the liver tissue showed increased hepatocyte ballooning and endothelial cell TUNEL positivity. This was followed by progressive hepatocyte necrosis from perivascular region at day 7 to lobular region by day 11. ACLF (day 7 and day 11) animals showed increase in bilirubin (p < 0.05), prothrombin time (p < 0.0001), blood ammonia (p < 0.001), and portal pressure post-acute hepatocellular injury similar to human ACLF. Ascites was noticed by day 11 with median serum-ascites albumin gradient of 1.2 (1.1–1.3) g/dL. In comparison to cirrhosis, ACLF group (day 7 and day 11) showed significant decrease in Sirius red (p ≤ 0.0001), collagen1 (p < 0.0001), and a-SMA proportionate area (p < 0.0001) with loss of hepatocytes regeneration (p < 0.005). At day 11, ACLF animals also showed significant increase in serum creatinine (p < 0.05) and acute tubular necrosis suggestive of organ failure, compared to cirrhotic animals.
Conclusion
The CCL4/APAP/LPS (CALPS) model of ACLF mimics the clinical, biochemical, and histological features of ACLF with demonstrable progressive hepatocellular necrosis, liver failure, impaired regeneration, development of portal hypertension, and organ dysfunction in an animal with chronic liver disease.
Graphic abstract
Similar content being viewed by others
Abbreviations
- ACLF:
-
Acute-on-chronic liver failure
- CCl4 :
-
Carbon tetrachloride
- APAP:
-
Acetaminophen
- LPS:
-
Lipopolysaccharide
- ATN:
-
Acute tubular necrosis
- SAAG:
-
Serum-ascites albumin gradient
- SIRS:
-
Systemic inflammatory response
- TUNEL:
-
Terminal deoxynucleotidyl transferase dUTP nick end labeling
References
Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanismsand management. Nat Rev Gastroenterol Hepatol 2016;13(3):131–149
Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, et al. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016;9(2):16041
Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, et al. Acute-on-chronic liver failure: getting ready for prime time? Hepatology 2018;68(4):1621–1632
Wu T, Li J, Shao L, Xin J, Jiang L, Zhou Q, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut 2018;67(12):2181–2191
Zhao RH, Shi Y, Zhao H, Wu W, Sheng JF. Acute-on-chronic liver failure in chronic hepatitis B: an update. Expert Rev Gastroenterol Hepatol 2018;12(4):341–350
Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, et al. Acute-on chronic liver failure. J Hepatol 2012;57(6):1336–1348
Finkenstedt A, Nachbaur K, Graziadei W, Vogel W. Acute on chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl 2013;19:879–886
Kuhla A, Eipel C, Abshagen K, Siebert N, Menger MD, Vollmar B. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury. Am J Physiol Gastrointest Liver Physiol 2009;296(5):G1069–G1076
Li X, Wang LK, Wang LW, Han XQ, Yang F, Gong ZJ. Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. Inflamm Res 2013;62(7):703–709
Balasubramaniyan V, Dhar DK, Warner AE, Vivien Li WY, Amiri AF, Bright B, et al. Importance of connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure. J Hepatol 2013;58(6):1194–1200
Li F, Miao L, Sun H, Zhang Y, Bao X, Zhang D. Establishment of a new acute-on-chronic liver failure model. Acta Pharm Sin B 2017;7(3):326–333
Tripathi DM, Vilaseca M, Lafoz E, Garcia-Calderó H, Viegas Haute G, Fernandez-Iglesias A, et al. Simvastatin prevents progression of acute on chronic liver failure in rats with cirrhosis and portal hypertension. Gastroenterology 2018;155(5):1564–1577
Xiang X, Feng D, Hwang S, Ren T, Wang X, Trojnar E, et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. J Hepatol. 2020;72(4):736–745
Fernández J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67(10):1870–8180
Clària J, Arroyo V, Moreau R. The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray. J Immunol 2016;197(10):3755–3761
Yang L, Wu T, Li J, Li J. Bacterial infections in acute-on-chronic liver failure. Semin Liver Dis 2018;38(2):121–133
Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) 2014. Hepatol Int 2014;8(4):453–471
Sarin SK, Choudhury A, Sharma MK, Maiwall R, Alahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int 2019;13(4):353–390
Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of ‘golden window’: a prospective study. J Gastroenterol Hepatol 2017;32(12):1989–1997
Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, Roskams T, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010;59(11):1561–1569
Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 2009;69(6):479–491
Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salerno F. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 2009;51(3):475–482
Bhushan B, Apte U. Liver regeneration after acetaminophen hepatotoxicity: mechanisms and therapeutic opportunities. Am J Pathol 2019;189(4):719–729
Shubham S, et al. Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure. Hepatol Int 2019;13(6):777–877
Hernaez R, Solà E, Moreau R, Ginès P. Acute-on-chronic liver failure: an update. Gut 2017;66(3):541–553
Rastogi A, Maiwall R, Bihari C, Trehanpati N, Pamecha V, Sarin SK. Two-tier regenerative response in liver failure in humans. Virchows Arch 2014;464:565–573
Chen LY, et al. Promotion of mitochondrial energy metabolism during hepatocyte apoptosis in a rat model of acute liver failure. Mol Med Rep 2015;12(4):5035–5041
Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102(3):538–549
Mehendale HM. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 2005;33(1):41–51
Maiwall R, et al. AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis. Hepatol Int 2015;9(4):627–639
Acknowledgements
This work was supported by Science and Engineering Research Board (SERB), Government of India Grant IR/SB/EF/02/2016.
Funding
This work was supported by Science and Engineering Research Board (SERB), Government of India Grant IR/SB/EF/02/2016.
Author information
Authors and Affiliations
Contributions
NN, AK, and SKS contributed to the design of the studies. NN performed the majority of experiments, with assistance from MD, KD, KR, and PA. DMT and NN contributed in hemodynamics assessment. GS and SM help in RT-PCR. SS helped in western blot. CB and RA help in histopathology analysis. AK, RM, SB, and SKS assisted with interpretation of the findings. The manuscript was written by NN and AK with critical input from SKS and RM.
Corresponding authors
Ethics declarations
Ethics approval
Animal care and all experimental procedures were approved by the Institutional Animal Ethics Committee (IAEC) under the project approval (IAEC/ILB/17/03) from Department of Science and Technology, Government of India.
Conflict of interest
Nautiyal Nidhi, Maheshwari Deepanshu, Tripathi Dinesh Mani, Kumar Dhananjay, Kumari Rekha, Gupta Suchi, Sharma Sachin, Mohanty Sujata, Parasar Anupama, Bihari Chhagan, Biswas Subhrajit, Rastogi Archana, Maiwall Rakhi, Kumar Anupam, Shiv Kumar Sarin have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Nautiyal, N., Maheshwari, D., Tripathi, D.M. et al. Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction. Hepatol Int 15, 1389–1401 (2021). https://doi.org/10.1007/s12072-021-10244-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-021-10244-0